Should you sell or license your patent? The keep-your-title decision

The legal mechanics differ in ways that matter commercially. An assignment must be in writing and should be recorded, because an unrecorded one can lose out to a later buyer. A license can be cut to fit: one field of use, one region, one product line, or a set number of years. Several non-exclusive licenses can run at once in different markets, which is how a patent whose claims reach further than the owner's own product earns from all of them.

Payment terms follow the structure. A sale is usually a lump sum, sometimes with installments or later payments tied to results. A license can be an upfront fee, a running royalty, milestone payments, or a mix. Counsel drafts and closes either one, and the structure should be settled with counsel before any price is discussed with a counterparty.

A clean sale to a defensive buyer is a real exit, and the fixed-price programs those buyers run publish their results. The figures below show the price range those programs paid and how most offers were priced. They also show that a share of the deals were group licenses rather than sales, which is a reminder that even buyers built to acquire will often take a license instead.

Licensing is more work than a sale. Each license needs a counterparty who is convinced, and inside a manufacturer that usually means more than one group: the people who design the product, the people who manage legal risk, and the people who sell it. A licensing program needs someone to run it. For an owner whose claims reach several markets, that work is usually worth it, because the alternative is a single payment for rights that could have earned in each of them.

The buyer data below comes from a decade-old market report and from the latest published results of a defensive buyer's fixed-price program, and the two point the same way. Most patents offered for sale are single families, most are priced modestly, and the most competitive offers come with evidence of use and claim charts. Operating companies that buy usually do so to clear a risk, to secure freedom for a product, or to strengthen a position against a competitor, and they buy from owners who can show why the patent matters to that product.

For the owner, the useful reading is that a sale price is set by the buyer's need, not by the cost of the invention. An owner who knows which company needs the patent most, and why, can negotiate from that need. An owner who does not know yet should find out before deciding between sale and license, because the answer often decides the question.

Buyers at large operating companies have said this plainly in public: their patent activity is mostly defensive, and the patents they worry about most are the ones a company sells to someone who will assert them. For a seller, the risk runs the other way. A patent that covers features your customers use, sold to an assertion entity, can come back as a demand letter to those customers, and the relationship damage can cost more than the sale brought in.

There are structures that manage this. A license that excludes your customers' use of your products, a sale with a license back to you and your customers, or a sale restricted to buyers who will not assert against named categories are all worth discussing with counsel. None of them is automatic, and each one changes the price.

A non-exclusive license in one field leaves title and every other field with the owner, so a later sale is still possible, usually subject to the license. An exclusive license in a field can make a later buyer pay less, because part of what it would buy is already granted. Group licenses to a buyer pool can lock the owner out of a sale for a fixed term, as the program terms below show.

The reverse sequence is harder. Once title is sold, the seller has only what the agreement reserves, such as a license back or a share of later income. That asymmetry is the main reason to decide slowly: a license can usually be followed by a sale, while a sale can rarely be followed by anything.

Know the patent's actual expiry date before deciding anything. Continuations and terminal disclaimers can make a patent expire earlier than its own filing date suggests, and an owner who plans a licensing program around the wrong date will plan it wrong. Counsel can confirm the date from the file history.

A maintenance window is also a natural deadline for the decision. If the next fee is due soon and there is no buyer or licensee in view, an owner is choosing between paying to keep options open and letting the asset go. Starting the sale or license conversation well before the window keeps that choice in the owner's hands.

Patenture starts from the question this guide ends on: who needs the patent and what deal they would sign. For an owner with no market answer yet, that is the Claim to Market Read. For an owner whose product already uses the patent and whose claims reach further, it is the Licensing Reach Read.

For an owner who already knows the buyer and is weighing a sale against a license, the work starts with the Mandate Review: about a week, ending in a thesis test, a deal shape, the diligence gaps, and a written yes or no on whether we take the mandate. Patent counsel drafts and closes every license and sale.